BTX-A as a novel therapeutic approach for DED
Traditional dry eye disease (DED) management strategies encompass artificial tears, anti-inflammatory agents and punctal plugs. However, a subset of patients remains refractory to these treatments, necessitating alternative therapeutic approaches. While dry eye can be an inadvertent side-effect of b
3 min read